Publications by authors named "Arghya Ray"

Claim this Profile
A
A BCMA-mRNA vaccine is a promising therapeutic for multiple myeloma.
Debasmita Dutta, Jiye Liu, Kenneth Wen, Arghya Ray, Alessandro Salatino

Blood· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Siglec-sialic acid checkpoint to reverse immune dysfunction mediated by plasmacytoid dendritic cells in myeloma.
Arghya Ray, Leutz Buon, Xueping Wan, Ting Du, Yan Song

Blood Adv· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Editor's Note: Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells.
Deepika Sharma Das, Abhishek Das, Arghya Ray, Yan Song, Mehmet Kemal Samur

Clin Cancer Res· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel small molecule inhibitor of CD73 triggers immune-mediated multiple myeloma cell death.
Arghya Ray, Ting Du, Xueping Wan, Yan Song, Sindhu C Pillai

Blood Cancer J· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Ubiquitin receptor PSMD4/Rpn10 is a novel therapeutic target in multiple myeloma.
Ting Du, Yan Song, Arghya Ray, Xueping Wan, Yao Yao

Blood· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mycetoma caused by in immunocompromised patients - a case report and systematic literature review.
Lotje A Hoogervorst, Lindsey S Op de Coul, Arghya Ray, Pieter Bas de Witte, Mark G J de Boer

J Bone Jt Infect· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification and validation of ecto-5' nucleotidase as an immunotherapeutic target in multiple myeloma.
Arghya Ray, Yan Song, Ting Du, Leutz Buon, Yu-Tzu Tai

Blood Cancer J· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of a Clinical Teaching Unit in Internal Medicine to Promote Interprofessional and Multidisciplinary Learning: A Practical Intervention.
Esther C Hamoen, Floris M van Blankenstein, Peter G M de Jong, Arghya Ray, Marlies E J Reinders

Teach Learn Med· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma.
Arghya Ray, Yan Song, Ting Du, Dharminder Chauhan, Kenneth C Anderson

Oncogene· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting ubiquitin-specific protease-7 in plasmacytoid dendritic cells triggers anti-myeloma immunity.
Arghya Ray, Ting Du, Yan Song, Sara J Buhrlage, Dharminder Chauhan

Leukemia· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proteomic analysis identifies mechanism(s) of overcoming bortezomib resistance via targeting ubiquitin receptor Rpn13.
Ting Du, Yan Song, Arghya Ray, Dharminder Chauhan, Kenneth C Anderson

Leukemia· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of novel anti-tumor therapeutic target via proteomic characterization of ubiquitin receptor ADRM1/Rpn13.
Yan Song, Ting Du, Arghya Ray, Krishan Chauhan, Mehmet Samur

Blood Cancer J· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma.
Arghya Ray, Yan Song, Ting Du, Dharminder Chauhan, Kenneth C Anderson

Oncogene· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective USP7 inhibition elicits cancer cell killing through a p53-dependent mechanism.
Nathan J Schauer, Xiaoxi Liu, Robert S Magin, Laura M Doherty, Wai Cheung Chan, Arghya Ray

Sci Rep· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting tryptophan catabolic kynurenine pathway enhances antitumor immunity and cytotoxicity in multiple myeloma.
Arghya Ray, Yan Song, Ting Du, Yu-Tzu Tai, Dharminder Chauhan

Leukemia· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and preclinical validation of a novel covalent ubiquitin receptor Rpn13 degrader in multiple myeloma.
Yan Song, Paul M C Park, Lei Wu, Arghya Ray, Sarah Picaud

Leukemia· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of ubiquitin receptor Rpn13 in plasmacytoid dendritic cells triggers anti-myeloma immunity.
Arghya Ray, Yan Song, Dharminder Chauhan, Kenneth C Anderson

Blood Cancer J· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockade of Deubiquitylating Enzyme USP1 Inhibits DNA Repair and Triggers Apoptosis in Multiple Myeloma Cells.
Deepika Sharma Das, Abhishek Das, Arghya Ray, Yan Song, Mehmet Kemal Samur

Clin Cancer Res· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel alkylating agent Melflufen induces irreversible DNA damage and cytotoxicity in multiple myeloma cells.
Arghya Ray, Durgadevi Ravillah, Deepika S Das, Yan Song, Eva Nordström

Br J Haematol· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synergistic anti-myeloma activity of the proteasome inhibitor marizomib and the IMiD immunomodulatory drug pomalidomide.
Deepika S Das, Arghya Ray, Yan Song, Paul Richardson, Mohit Trikha

Br J Haematol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A novel small molecule inhibitor of deubiquitylating enzyme USP14 and UCHL5 induces apoptosis in multiple myeloma and overcomes bortezomib resistance.
Ze Tian, Padraig D'Arcy, Xin Wang, Arghya Ray, Yu-Tzu Tai

Blood· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vitro and in vivo antitumor activity of a novel alkylating agent, melphalan-flufenamide, against multiple myeloma cells.
Dharminder Chauhan, Arghya Ray, Kristina Viktorsson, Jack Spira, Claudia Paba-Prada

Clin Cancer Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reversible resistance induced by FLT3 inhibition: a novel resistance mechanism in mutant FLT3-expressing cells.
Ellen Weisberg, Arghya Ray, Erik Nelson, Sophia Adamia, Rosemary Barrett

PLoS One· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells.
Dharminder Chauhan, Madhavi Bandi, Ajita V Singh, Arghya Ray, Noopur Raje

Br J Haematol· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antileukemic Effects of Novel First- and Second-Generation FLT3 Inhibitors: Structure-Affinity Comparison.
Ellen Weisberg, Johannes Roesel, Pascal Furet, Guido Bold, Patricia Imbach, Arghya Ray

Genes Cancer· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis